I have gone along with the popular belief that a positive FDA decision for Dendreon will result in a share price rerating for Prima.
However, will this in fact be the case?
Perhaps the only thing that will cause a re-rating of the PRR share price will be more boxes being ticked on the way to commercialisation.
E.g.,
Orphan status decision/s.
Trials progress reports.
Takeover interest.
Nasdaq listing.
I am preparing myself for the possibility that the Dendreon FDA decision will not have any impact on PRR -either way. If it was going to, it should have done so already. Afterall, the speculation of a positive decision for Dendreon has been going on and on for several months and has been reflected in an increasing share price. Not so with Prima.
- Forums
- ASX - By Stock
- IMM
- high expectations on dendreon fda decision
high expectations on dendreon fda decision
-
- There are more pages in this discussion • 30 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMM (ASX) to my watchlist
|
|||||
Last
34.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $501.1M |
Open | High | Low | Value | Volume |
34.0¢ | 34.5¢ | 33.5¢ | $1.172M | 3.429M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 29990 | 34.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
35.0¢ | 174098 | 8 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 29990 | 0.340 |
1 | 22896 | 0.335 |
10 | 436920 | 0.330 |
5 | 66050 | 0.325 |
7 | 147080 | 0.320 |
Price($) | Vol. | No. |
---|---|---|
0.350 | 174098 | 8 |
0.355 | 124396 | 6 |
0.360 | 135084 | 7 |
0.365 | 158497 | 7 |
0.370 | 398916 | 8 |
Last trade - 16.10pm 31/07/2024 (20 minute delay) ? |
Featured News
IMM (ASX) Chart |
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, CEO
Anthony Noble
CEO
SPONSORED BY The Market Online